tiprankstipranks
Tenax Therapeutics (TENX)
NASDAQ:TENX
US Market

Tenax Therapeutics (TENX) Financial Statements

Compare
568 Followers

Tenax Therapeutics Financial Overview

Tenax Therapeutics's market cap is currently $26.01M. The company's EPS TTM is $-5.306; its P/E ratio is ―; Tenax Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -7.57K$ -113.33K$ -108.98K$ -114.75K
Operating Income$ 0.00-$ -11.05M$ -32.73M$ -9.87M
EBITDA$ 0.00$ -8.23M$ -10.93M$ -32.36M$ -9.74M
Net Income$ -17.60M$ -7.71M$ -11.04M$ -32.73M$ -9.87M
Balance Sheet
Cash & Short-Term Investments$ 94.85M$ 9.79M$ 2.12M$ 5.58M$ 6.71M
Total Assets$ 96.69M$ 11.68M$ 3.40M$ 5.99M$ 6.87M
Total Debt$ 0.00$ 500.90K$ 807.89K$ 290.78K$ 305.04K
Net Debt$ -94.85M$ -9.29M$ -1.32M$ -5.29M$ -5.95M
Total Liabilities$ 4.69M$ 3.59M$ 1.91M$ 1.75M$ 2.24M
Stockholders' Equity$ 91.99M$ 8.10M$ 1.49M$ 4.24M$ 4.63M
Cash Flow
Free Cash Flow$ -14.81M$ -5.90M$ -12.02M$ -10.86M$ -9.28M
Operating Cash Flow$ -14.81M$ -5.90M$ -12.01M$ -10.86M$ -9.27M
Investing Cash Flow$ 0.00$ 2.84K$ -2.32K$ 452.61K$ 20.11K
Financing Cash Flow$ 99.87M$ 13.57M$ 8.55M-$ 10.60M
Currency in USD

Tenax Therapeutics Earnings and Revenue History

Tenax Therapeutics Debt to Assets

Tenax Therapeutics Cash Flow

Tenax Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis